T 1625/12 (Single domain antibodies/DOMANTIS) of 27.10.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T162512.20171027
- Date of decision
- 27 October 2017
- Case number
- T 1625/12
- Online on
- 3 November 2017
- Petition for review of
- -
- Application number
- 04737302.2
- IPC class
- C07K 16/24A61K 47/48
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pegylated single domain antibodies (dAb)
- Applicant name
- Domantis Limited
- Opponent name
- Boehringer Ingelheim International GmbH/
Boehringer Ingelheim Pharma GmbH & Co.KG
Ablynx N.V. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 84(1)European Patent Convention R 100(1)
- Keywords
- Lapse of patent in all designated states - continuation of appeal proceedings (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.